Biomedical Advanced Research and Development Authority (BARDA)

Investor type Government Office


Unlock datapoints

Portfolio analytics



News & Media

Add fund to favorites
Save this fund for later to form your own custom list of funds
This summary is composed by our algorithm based on the analysis of the deals. If you think that some of this information is not accurate, please let us know about it and provide any supporting evidences if possible. Such cases will be analyzed by our ML-algorithm and implemented in our database, which will improve this summary.
Total investments 38
Average round size
The average size of a deal this fund participated in
Portfolio companies 31
Rounds per year 2.38
Lead investments 7
Follow on index
How often the fund supports its portfolio startups at next rounds
Exits 17
Key employees Soon

Areas of investment

  • Health Care
  • Biotechnology
  • Medical
  • Pharmaceutical
  • Medical Device

Related Funds

Funds investing in previous rounds
These funds often invest in the rounds preceeding the rounds of Biomedical Advanced Research and Development Authority (BARDA):
Typical Co-investors
Biomedical Advanced Research and Development Authority (BARDA) is more likely to invest in rounds together with the following funds:
There are no funds here. If we find new data, we will add it here.
Funds investing in following rounds
These funds have a tendency to invest in the following rounds after Biomedical Advanced Research and Development Authority (BARDA):
There are no funds here. If we find new data, we will add it here.

Look at other 50 related and similar funds Collapse list
Fund NameLocation
BlackSoil India, Maharashtra, Mumbai
Clearance -
Czech Venture Capital Association Czech Republic, Prague, Prague
Everblu Capital Australia, New South Wales, Sydney
EXTOREL Bayern, Germany, Munich
Hamilton Ventures LLC Atlanta, Georgia, United States
Hartwig -
Imperial College Business School England, London, United Kingdom
Institute for Systems Biology Seattle, United States, Washington
Jiayi IEIG -
Kereon Partners Community of Madrid, Madrid, Spain
Oman India Joint Investment Fund India, Maharashtra, Mumbai
Proterra Investment Partners Minneapolis, Minnesota, United States
Radio Unica Communications Florida, Miami, United States
the Way Forward Aps -
TheVentures Seoul, Seoul-t'ukpyolsi, South Korea
UCLA Ventures California, Los Angeles, United States
Vuzix New York, Rochester, United States
Yehe Investment China, Chongming, Chongming District
Zanichelli Venture Bologna, Emilia-Romagna, Italy

Notable deals

CompanyIndustryRound SizeDateInvestorsLocation

BugSeq Bioinformatics

03 May 2022 Vancouver, British Columbia, Canada

Visby Medical

Health Care
Health Diagnostics
$25M22 Mar 2022 San Jose, California, United States

The Stevanato Group

Health Care
$95M01 Mar 2022 Veneto, Veneto, Italy

Spero Therapeutics

Medical Device
$12M19 Jan 2022 Cambridge, Massachusetts, United States

Basilea Pharmaceutica

$4M16 Aug 2021 Basel, Basel-Stadt, Switzerland


Health Diagnostics
$27M29 Jul 2021 Sunnyvale, California, United States

SeLux Diagnostics

Health Care
Health Diagnostics
$14M08 Jun 2021 Boston, Massachusetts, United States

Visby Medical

Health Care
Health Diagnostics
$12M02 Feb 2021 San Jose, California, United States

First Light Diagnostics

Health Care
Information Technology
$4M27 Oct 2020 Massachusetts, United States


  • No reviews are submitted yet.
Do you want more?
We provide dozens of additional datapoints about this fund.
Sign up and get access to full fund profile and advanced analysis.
Full team
Industries heatmap
Stages heatmap
Georgaphy breakdown
Portfolio analysis
Performance indexes
Latest highlights
Unlock all data
Do you represent Biomedical Advanced Research and Development Authority (BARDA)?
Get access to manage this page
Get in touch
Found incorrect info? Let us know!

You can raise money with us faster

Get matched with relevant funds

Find decision makers data

Connect with investors by email

Remind me later
...and save more than 200 hours*
*-Our recommendation and outreach system saves up to 200 hours of founder time on fundraising for seed and series A+ startups
We use LinkedIn only to verify your account. We don't import or message your contacts, nor post on your behalf.
By creating an account, you agree to our Terms of Service and Privacy Policy.
Crunchbase icon

Content report

The following text will be sent to our editors: